Expression of cannabinoid receptors and neurotrophins in human gliomas

Neurological Sciences

Volumn 28, Issue 6, 2007, Pages 304-310

  Calatozzolo, C ^a   Salmaggi, A ^a   Pollo, B ^a   Sciacca, F L ^a   Lorenzetti, M ^a   Franzini, A ^a   Boiardi, A ^a   Broggi, G ^a   Marras, C ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

CB1; CB2; Glioma; NGF; NT 3; TrkA; TrkC

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE KINASE C; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; RECEPTORS, CANNABINOID; RNA, MESSENGER;

EID: 38049025796     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-007-0843-8     Document Type: Article

References (35)

1. Velasco L, Ruiz L, Sánchez MG, Díaz-Laviada I (2001) Δ(9)-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1. Eur J Biochem 268:531-535
2. Melck D, De Petrocellis L, Orlando P et al (2000) Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141:118-126
3. De Petrocellis L, Melck D, Palmisano A et al (1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci U S A 95:8375-8380
4. Portella G, Laezza C, Laccetti P et al (2003) Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: Actions on signals involved in angiogenesis and metastasis. FASEB J 17:1771-1773
5. Casanova ML, Blazquez C, Martinez-Palacio J et al (2003) Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111:43-50
6. Velasco G, Galve-Roperh I, Sanchez C et al (2004) Hypothesis: cannabinoid therapy for the treatment of gliomas? Neuropharmacology 47:315-323
7. Galve-Roperh I, Sanchez C, Cortes ML et al (2000) Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 6:313-319
8. Blazquez C, Gonzalez-Feria L, Alvarez L et al (2004) Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res 64:5617-5623
9. Gerard CM, Mollereau C, Vassart G, Parmentier M (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279:129-134
10. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65
11. Nunez E, Benito C, Pazos MR et al (2004) Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study. Synapse 53:208-213
12. Held-Feindt J, Dorner L, Sahan G et al (2006) Cannabinoid receptors in human astroglial tumors. J Neurochem 98:886-893
13. Sanchez C, de Ceballos ML, del Pulgar TG et al (2001) Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 61:5784-5789
14. McAllister SD, Chan C, Taft RJ et al (2005) Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells. J Neurooncol 74:31-40
15. Hart S, Fischer OM, Ullrich A (2004) Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res 6:1943-1950
16. Gómez del Pulgar T, Velasco G, Sánchez C et al (2002) De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem J 363:183-188
17. Gómez del Pulgar T, de Ceballos ML, Guzmán M, Velasco G (2002) Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 277:36527-36533
18. Singer HS, Hansen B, Martinie D, Karp CL (1999) Mitogenesis in glioblastoma multiforme cell lines: A role for NGF and its TrkA receptors. J Neurooncol 45:1-8
19. Kokunai T, Iguchi H, Tamaki N (1999) Differentiation and growth inhibition of glioma cells induced by transfer of trk A proto-oncogene. J Neurooncol 42:23-34 23-34
20. Watanabe T, Katayama Y, Kimura S, Yoshino A (1999) Control of proliferation and survival of C6 glioma cells with modification of the nerve growth factor autocrine system. J Neurooncol 41:121-128
21. Pflug BR, Colangelo AM, Tornatore C, Mocchetti I (2001) TrkA induces differentiation but not apoptosis in C6-2B glioma cells. Neurosci Res 64:636-645
22. Kimura S, Yoshino A, Katayama Y et al (2002) Growth control of C6 glioma in vivo by nerve growth factor. J Neurooncol 59:199-205
23. Wang Y, Hagel C, Hamel W et al (1998) Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma. Acta Neuropathol (Berl) 96:357-364
24. Wadhwa S, Nag TC, Jindal A et al (2003) Expression of the neurotrophin receptors Trk A and Trk B in adult human astrocytoma and glioblastoma. J Biosci 28:181-188
25. Chiaretti A, Aloe L, Antonelli A et al (2004) Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas. Childs Nerv Syst 20:412-419
26. Kim JY, Sutton ME, Lu DJ et al (1999) Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Res 59:711-719
27. Blazquez C, Casanova ML, Planas A et al (2003) Inhibition of tumor angiogenesis by cannabinoids. FASEB J 17:529-531
28. Tamagno I, Shiffer D (2006) Nestin expression in reactive astrocytes of human pathology. J Neurooncol 80:227-233
29. Ray A, Ho M, Ma J et al (2004) A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 10:7613-7620
30. Kim JY, Sutton ME, Lu DJ et al (1999) Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Res 59:711-719
31. Denkins Y, Reiland J, Roy M et al (2004) Brain metastases in melanoma: roles of neurotrophins. Neuro-oncology 6:154-165
32. Emanueli C, Schratzberger P, Kirchmair R, Madeddu P (2003) Paracrine control of vascularization and neurogenesis by neurotrophins. Br J Pharmacol 140:614-619
33. Takeo C, Nakamura S, Tanaka T et al (2003) Rat cerebral endothelial cells express trk C and are regulated by neurotrophin-3. Biochem Biophys Res Commun 305:400-406
34. Guzman M, Duarte MJ, Blasquez C et al (2006) A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer 95:197-203
35. Walsh D, Nelson KA, Mahmoud FA (2003) Established and potential therapeutic applications of cannabinoids in oncology. Support Care Cancer 11:137-143